Gene,disease_list
CASP7,"{'Niemann-Pick disease A (NPDA) [MIM', 'Spastic paraplegia 76, autosomal recessive (SPG76) [MIM', 'Liberfarb syndrome (LIBF) [MIM', 'Niemann-Pick disease B (NPDB) [MIM', 'Gabriele-de Vries syndrome (GADEVS) [MIM', 'Knobloch syndrome 2 (KNO2) [MIM', 'Cerebellar ataxia, cayman type (ATCAY) [MIM', 'Note=Autoantigen in rheumatoid arthritis. {ECO', 'Oocyte/zygote/embryo maturation arrest 7 (OZEMA7) [MIM', 'Hemolytic anemia, congenital, X-linked (HACXL) [MIM', 'Cataract 33, multiple types (CTRCT33) [MIM', 'Lymphoproliferative syndrome, X-linked, 2 (XLP2) [MIM'}"
CD4,"{'Immunodeficiency with hyper-IgM, type 1 (HIGM1) [MIM', 'Rheumatoid arthritis (RA) [MIM', 'Type 1 diabetes mellitus 22 (T1D22) [MIM', 'Note=In populations of European descent, allele DRB1*01', 'DRB1*04:08', 'Spastic paraplegia 21, autosomal recessive (SPG21) [MIM', 'DRB1*04:05', 'DRB1*04:04', 'DISEASE: Note=Aberrant PTK2/FAK1 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. PTK2/FAK1 overexpression is seen in many types of cancer.', 'Immunodeficiency 79 (IMD79) [MIM', 'Note=Allele DRB1*15', 'DRB1*01:01 and DRB1*01:02 are associated with increased susceptibility to rheumatoid arthritis, where affected individuals have antibodies to cyclic citrullinated peptide (anti-CCP-positive rheumatoid arthritis). Variations at position 40 in the peptide-binding cleft of these alleles explain most of the association to rheumatoid arthritis risk. {ECO:0000269|PubMed:22286218}.', 'Immunodeficiency 102 (IMD102) [MIM', 'Sarcoidosis 1 (SS1) [MIM', 'Immunodeficiency 19, severe combined (IMD19) [MIM', 'Multiple sclerosis (MS) [MIM', 'DRB1*10:01', 'Immunodeficiency 105, severe combined (IMD105) [MIM'}"
EDN1,"{'Hirschsprung disease 2 (HSCR2) [MIM', 'ABCD syndrome (ABCDS) [MIM', 'Waardenburg syndrome 4A (WS4A) [MIM', 'Auriculocondylar syndrome 3 (ARCND3) [MIM', 'Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections (HIES1) [MIM', 'Question mark ears, isolated (QME) [MIM', 'Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM', 'Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities (NEDFASB) [MIM', 'Mandibulofacial dysostosis with alopecia (MFDA) [MIM', 'Note=Heterozygous mutations in EDNRB may be responsible for Waardenburg syndrome 2, an autosomal dominant disorder characterized by sensorineural deafness and pigmentary disturbances. {ECO'}"
MAOB,"{'Coenzyme Q10 deficiency, primary, 4 (COQ10D4) [MIM', 'Brunner syndrome (BRNRS) [MIM', 'Thyroid cancer, non-medullary, 2 (NMTC2) [MIM', 'Mitochondrial complex IV deficiency, nuclear type 11 (MC4DN11) [MIM', 'Spinocerebellar ataxia 27A (SCA27A) [MIM', 'Achondroplasia, severe, with developmental delay and acanthosis nigricans (SADDAN) [MIM', 'Thanatophoric dysplasia 1 (TD1) [MIM', 'Congenital arthrogryposis with anterior horn cell disease (CAAHD) [MIM', 'Note=Mutations which change positions 12, 13 or 61 activate the potential of HRAS to transform cultured cells and are implicated in a variety of human tumors. {ECO', 'Amyloidosis, hereditary systemic 4, Finnish type (AMYLD4) [MIM', 'Spinocerebellar ataxia 27B, late-onset (SCA27B) [MIM', 'q32.3) with the IgH locus.', 'Myasthenic syndrome, congenital, 6, presynaptic (CMS6) [MIM', 'Hypochondroplasia (HCH) [MIM', 'Camptodactyly, tall stature, and hearing loss syndrome (CATSHLS) [MIM', '14)(p16.3', 'Costello syndrome (CSTLO) [MIM', 'Testicular germ cell tumor (TGCT) [MIM', 'Maturity-onset diabetes of the young 7 (MODY7) [MIM', 'Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM', 'Thanatophoric dysplasia 2 (TD2) [MIM', 'Lacrimo-auriculo-dento-digital syndrome 2 (LADD2) [MIM', 'Muenke syndrome (MNKS) [MIM', 'Congenital myopathy with excess of muscle spindles (CMEMS) [MIM', 'Legius syndrome (LGSS) [MIM', 'Achondroplasia (ACH) [MIM', 'Crouzon syndrome with acanthosis nigricans (CAN) [MIM', 'Cervical cancer (CERCA) [MIM', 'Keratinocytic non-epidermolytic nevus (KNEN) [MIM', 'Danon disease (DAND) [MIM', 'Lethal congenital contracture syndrome 1 (LCCS1) [MIM', 'Bladder cancer (BLC) [MIM', 'Keratosis, seborrheic (KERSEB) [MIM', 'Multiple myeloma (MM) [MIM'}"
MAPK1,"{'Cardiofaciocutaneous syndrome 3 (CFC3) [MIM', 'Retinitis pigmentosa 67 (RP67) [MIM', 'Gastrointestinal stromal tumor (GIST) [MIM', 'Neurodevelopmental disorder with midbrain and hindbrain malformations (NEDMHM) [MIM', 'Note=Involved in tumorigenic rearrangements with the MET. {ECO', 'Melorheostosis, isolated (MEL) [MIM', 'Lung cancer (LNCR) [MIM', 'Colorectal cancer (CRC) [MIM', 'q21) with RARA. The PML breakpoints (type A and type B) lie on either side of an alternatively spliced exon. {ECO:0000269|PubMed:1652369, ECO:0000269|PubMed:1720570}.', 'DISEASE: Note=A chromosomal aberration involving PML may be a cause of acute promyelocytic leukemia (APL). Translocation t(15', '17)(q21', ""Note=A chromosomal aberration involving TPR has been found in papillary thyroid carcinomas (PTCs). Intrachromosomal rearrangement that links the 5'-end of the TPR gene to the protein kinase domain of NTRK1 forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the carboxy terminus of the NTRK1 protein. {ECO"", 'Note=Defects in BRAF are found in a wide range of cancers. {ECO', 'Mastocytosis, systemic (MASTSYS) [MIM', 'Testicular germ cell tumor (TGCT) [MIM', 'Hypogonadotropic hypogonadism 19 with or without anosmia (HH19) [MIM', 'Noonan syndrome 13 (NS13) [MIM', 'Cardiofaciocutaneous syndrome 1 (CFC1) [MIM', 'Noonan syndrome 7 (NS7) [MIM', 'Familial non-Hodgkin lymphoma (NHL) [MIM', 'Note=A chromosomal aberration involving BRAF is found in pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation. {ECO', 'Piebald trait (PBT) [MIM', 'Leukemia, acute myelogenous (AML) [MIM', 'LEOPARD syndrome 3 (LPRD3) [MIM', 'Neonatal nephrocutaneous inflammatory syndrome (NNCIS) [MIM', 'Intellectual developmental disorder, autosomal recessive 79 (MRT79) [MIM', 'Mastocytosis, cutaneous (MASTC) [MIM'}"
NFE2L2,"{'16)(p11', 'Nemaline myopathy 5A, autosomal recessive, severe infantile (NEM5A) [MIM', 'Nemaline myopathy 5B, autosomal recessive, childhood-onset (NEM5B) [MIM', 'p13.3) with KMT2A/MLL1', 'DISEASE: Note=Chromosomal aberrations involving CREBBP may be a cause of acute myeloid leukemias. Translocation t(8', 'DISEASE: Note=A chromosomal aberration disrupting CHD6 has been found in a patient with mild to moderate intellectual disability and minor facial anomalies. Translocation t(18', 'Rubinstein-Taybi syndrome 1 (RSTS1) [MIM', 'p13) with KAT6B. KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription.', '20)(q21.1', 'q11.2) with TCF4 producing a CHD6-TCF4 fusion transcript (PubMed:18627065). {ECO:0000269|PubMed:18627065}.', 'p13) with KAT6A', '16)(q23', 'Nemaline myopathy 5C, autosomal dominant (NEM5C) [MIM', 'Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) [MIM', 'Deafness, autosomal recessive, 35 (DFNB35) [MIM', 'Menke-Hennekam syndrome 1 (MKHK1) [MIM', '16)(q22', 'translocation t(10', 'translocation t(11', 'Wolcott-Rallison syndrome (WRS) [MIM'}"
P2RY1,"{'Nephrolithiasis/osteoporosis, hypophosphatemic, 2 (NPHLOP2) [MIM'}"
PLAT,"{'Ichthyosis, congenital, autosomal recessive 3 (ARCI3) [MIM', 'Note=Disease susceptibility may be associated with variants affecting the gene represented in this entry. Met at position 560 may confer interindividual susceptibility to coronary artery disease (CAD) (PubMed', 'Ichthyosis, congenital, autosomal recessive 2 (ARCI2) [MIM', 'Developmental and epileptic encephalopathy 49 (DEE49) [MIM', 'larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:11773004, ECO:0000269|PubMed:15629692, ECO:0000269|PubMed:16116617, ECO:0000269|PubMed:19131948, ECO:0000269|PubMed:19890349}. Note=The disease is caused by variants affecting the gene represented in this entry.', 'Note=Defects in PKD1L1 may be involved in autosomal recessive congenital chylothorax, a disorder belonging to the congenital lymphatic anomaly spectrum. Congenital chylothorax is characterized by antenatal chyle accumulation in the pleural cavity resulting in fetal lung compression, restricted venous blood flow to the heart and fetal hydrops. Frequently, affected fetuses die intrauterine or shortly after birth. In surviving infants, loss of chyle-soluble fluid leads to malnutrition, thrombophilia, and immunodeficiency. {ECO', 'skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background', 'Hepatic lipase deficiency (HL deficiency) [MIM', 'Esophageal cancer (ESCR) [MIM', 'Note=Increased activity of TPA results in increased fibrinolysis of fibrin blood clots that is associated with excessive bleeding. Defective release of TPA results in hypofibrinolysis that can lead to thrombosis or embolism. {ECO', 'Pancreatic lipase deficiency (PNLIPD) [MIM', 'Colorectal cancer (CRC) [MIM', 'Lipodystrophy, familial partial, 9 (FPLD9) [MIM', 'Heterotaxy, visceral, 8, autosomal (HTX8) [MIM', 'Plasminogen activator inhibitor-1 deficiency (PAI-1D) [MIM'}"
PTGS1,set()
SCN3A,"{'Generalized epilepsy with febrile seizures plus 1 (GEFSP1) [MIM', 'Dravet syndrome (DRVT) [MIM', 'Developmental and epileptic encephalopathy 11 (DEE11) [MIM', 'Developmental and epileptic encephalopathy 62 (DEE62) [MIM', 'Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM', 'Developmental and epileptic encephalopathy 52 (DEE52) [MIM', 'Atrial fibrillation, familial, 14 (ATFB14) [MIM', 'Generalized epilepsy with febrile seizures plus 2 (GEFSP2) [MIM', 'Brugada syndrome 5 (BRGDA5) [MIM', 'Note=Genetic variations in SCN2B may be involved in Brugada syndrome (PubMed', 'Note=Defects in SCN2A are associated with genetic epilepsy with febrile seizures plus (GEFS+), a familial autosomal dominant epilepsy syndrome, a clinical subset of febrile seizures, characterized by frequent episodes after 6 years of age and various types of subsequent epilepsy. {ECO', 'Seizures, benign familial infantile, 3 (BFIS3) [MIM', 'Epilepsy, familial focal, with variable foci 4 (FFEVF4) [MIM', 'Migraine, familial hemiplegic, 3 (FHM3) [MIM', 'Note=Defects in SCN2A are associated with autism spectrum disorders (ASD). It seems that mutations resulting in sodium channel gain of function and increased neuron excitability lead to infantile seizures, whereas variants resulting in sodium channel loss of function and decrease neuron excitability are associated with ASD. {ECO', 'Developmental and epileptic encephalopathy 6B (DEE6B) [MIM', 'Febrile seizures, familial, 3A (FEB3A) [MIM', 'Periventricular nodular heterotopia 7 (PVNH7) [MIM', 'Note=SCN1A mutations may be involved in Panayiotopoulos syndrome, a benign age-related focal seizure disorder occurring in early and mid-childhood. It is characterized by seizures, often prolonged, with predominantly autonomic symptoms, and by an electroencephalogram that shows shifting and/or multiple foci, often with occipital predominance. Autonomic seizures in Panayiotopoulos syndrome consist of episodes of disturbed autonomic function with emesis as the predominant symptom. Cardiorespiratory arrest is exceptional. {ECO', 'Episodic ataxia 9 (EA9) [MIM', 'Atrial fibrillation, familial, 13 (ATFB13) [MIM'}"
